Liver Extraction Ratio
Liver Extraction Ratio - Related Videos
12:13
Ex Situ Normothermic Machine Perfusion of Donor Livers
0 Views •
Cited by 21 •
2015
Here we present a protocol describing oxygenated ex situ machine perfusion of donor liver grafts. This article contains a step by step protocol to procure and prepare the liver graft for machine perfusion, prepare the perfusion fluid, prime the perfusion machine and perform oxygenated normothermic machine perfusion of the liver graft.
12:35
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
0 Views •
Cited by 14 •
2011
The study of liver sinusoidal endothelial cells (SECs) must be performed with primary cells obtained from the animal as no cell lines exist. This method relies on liver digestion and differential centrifugation for SEC purification for subsequent culturing and experimentation.
04:50
The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination
0 Views •
Cited by 4 •
2022
An optimal sucrose concentration was determined for the extraction of liver glycogen using sucrose density gradient centrifugation. The addition of a 10 min boiling step to inhibit glycogen-degrading enzymes proved beneficial.
01:28
Liquidity Ratios: Current Ratio
0 Views •
2024
Liquidity management involves strategically acquiring and using cash or near-cash resources, such as marketable securities, treasury bills, or short-term deposits, to ensure the company can meet its cash obligations as they come due. The current ratio, calculated by dividing current assets by current liabilities, is a valuable tool for evaluating a company's liquidity. Current assets are resources that can be quickly converted into cash, typically within a year. These include cash, cash...
01:28
Profitability Ratios: Net Profit Ratio
0 Views •
2024
The net profit ratio is a financial metric that evaluates a company's ability to convert revenue into actual profit after accounting for all expenses. It is significant for several reasons: Profitability Assessment: The ratio provides a clear indication of a company's overall profitability. A higher ratio means the company retains more profit from its revenues, indicating efficient cost management and strong financial health. Operational Efficiency: Companies can assess their operational...
FAQs
The ratio reflects the combined influence of delivery and processing: hepatic blood flow brings drug to the liver, the unbound fraction determines how much is available to enter hepatocytes, and intrinsic metabolic and transport capacity governs what the liver can process. Considering these factors together helps explain why drugs differ in extraction category and clearance behavior.
High-, intermediate-, and low-extraction classifications provide a comparative framework rather than a complete description of drug action. They indicate how efficiently hepatic factors remove a compound and help anticipate which changes in blood flow, protein binding, or hepatic capacity are most likely to alter exposure. This classification connects a mechanistic measurement with clinically relevant pharmacokinetic predictions.
Protein binding matters because the unbound portion is available for hepatic uptake and processing. A change in binding can therefore alter the amount presented to hepatocytes even when the total drug concentration appears unchanged. Interpreting liver extraction ratio alongside unbound fraction helps clarify why altered protein binding may change clearance or exposure.
Intrinsic metabolic and transport capacity represents the liver’s ability to process a drug once it reaches hepatocytes. Enzyme inhibition can reduce this capacity, while liver disease can impair hepatic handling more broadly. Because extraction depends on this capacity as well as delivery and binding, either condition may change drug exposure and influence the suitability of a usual dose.
In clinical pharmacokinetic assessment, the ratio can be used as an organizing measure: first consider hepatic blood flow, unbound fraction, and intrinsic metabolic or transport capacity; then classify the drug’s extraction behavior; finally evaluate how disease, inhibition, binding changes, or altered flow could modify exposure. This sequence supports interpretation without treating one determinant in isolation.
Clinicians use the classification to anticipate whether changes in hepatic physiology or drug handling could meaningfully affect concentrations. The ratio provides context when evaluating liver disease, enzyme inhibition, altered blood flow, or changed protein binding. Its practical value lies in linking those conditions to possible differences in clearance, exposure, dosing needs, or bioavailability.
Within clinical pharmacokinetics, liver extraction ratio helps connect hepatic drug handling with patient-specific treatment decisions. It can inform expectations about altered exposure and guide attention to dosing when hepatic disease or interacting factors affect processing. The same framework also supports interpretation of oral bioavailability, because hepatic extraction influences how much drug remains available after hepatic passage.